Sameer Nagpal, MD
Interventional Cardiology · New Haven, CTNPI 1912296401
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (38.3%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Cordis US CORP. at 25.1% of the total. Reporting peaked in 2022 at $19,114 and has fallen 88.8% since, to $2,142 in 2025. Among interventional cardiology clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $351.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cordis US CORP.$11K
- Veryan Medical Incorporated$10K
- Medtronic$8K
- Shockwave Medical, Inc$4K
- Cardinal Health 200 LLC$3K
- Cardiva Medical, Inc.$3K
- plus $4K from 13 others
Across 68 payments — averaging $1605.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$82K
- Medtronic$24K
- M.a. Med Alliance S.A.$4K
What the payments were for
- Consulting fees$16,39238%
- Speaking & faculty fees$7,20017%
- Travel & lodging$12,42529%
- Food & beverage$6,83016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cordis US CORP. | 4 | $10,736 |
| Veryan Medical Incorporated | 15 | $9,873 |
| Medtronic(2 entities) | 52 | $8,373 |
| Shockwave Medical, Inc | 7 | $3,820 |
| Cardinal Health 200 LLC | 7 | $3,449 |
| Cardiva Medical, Inc. | 2 | $2,732 |
| Abbott | 18 | $1,858 |
| BD | 1 | $492 |
| Cook Medical LLC | 4 | $465 |
| Boston Scientific | 3 | $264 |
| Inari Medical, Inc. | 1 | $212 |
| Asahi Intecc USA, Inc. | 1 | $141 |
| Corindus Inc. | 1 | $139 |
| Philips North America LLC | 1 | $125 |
| Abiomed | 1 | $110 |
| Angiodynamics, Inc. | 1 | $18 |
| Bard Peripheral Vascular, Inc. | 1 | $16 |
| Terumo Medical Corporation | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioMimics 3D Vascular Stent System$9,256
- Resolute$6,572
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$3,621
- Cardiva VASCADE MVP VVCS 6-12F$2,500
- Mynx Ace Vascular Closure Device$1,800
- Xience V coronary stent system$958
- Zilver PTX$240
- Vascular Closure Device$232
- Perclose ProGlide suture mediated closure system$226
- MYNX CONTROLTM$215
- FLOWTRIEVER CATHETER, S$212
- CT THROMBECTOMY SYSTEM KIT$212
- ASAHI PTCA Guide Wire$141
- CorPath GRX$139
- BioMimics$130
- Spectranetics Undiv$125
- Cook Medical Peripheral Intervention$124
- SYNERGY$118
- Xience Sierra Coronary Stent System$115
- Impella$110
How this compares
$42,847 in reported general payments places this provider in the 90th percentile of 73 interventional cardiology providers in Connecticut.
See all interventional cardiology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 67 | $87,413 |
| FarxigaDapagliflozin Propanediol | 12 | $21,165 |
| XareltoRivaroxaban | 13 | $15,822 |
| EntrestoSacubitril/Valsartan | 14 | $9,521 |
| Repatha SureclickEvolocumab | 15 | $8,450 |
| Rosuvastatin Calcium | 129 | $1,066 |
| Metoprolol Succinate | 74 | $956 |
| Atorvastatin Calcium | 51 | $557 |
| ClopidogrelClopidogrel Bisulfate | 58 | $498 |
| Ezetimibe | 28 | $430 |
| Losartan Potassium | 32 | $372 |
| Amlodipine Besylate | 62 | $368 |
| Carvedilol | 38 | $260 |
| Lisinopril | 21 | $235 |
| Spironolactone | 11 | $221 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in New Haven
- Amit VoraNew Haven$409K
- Michael NannaNew Haven$60K
- Michael ChrissoherisNew Haven$24K
- Hari DeshpandeNew Haven$23K
- Samit ShahNew Haven$19K
- Yasin HussainNew Haven$13K
- Brad StairNew Haven$7K
- Chirag ShahNew Haven$5K
- Scott WillisNew Haven$4K
- Rabih TabetNew Haven$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.